← All companies
NDRA
ENDRA Life Sciences Inc.
$4.18
-0.15 -3.46%
Key statistics
from XBRL data in SEC filingsMarket cap
$5.31M
Revenue (TTM)
$0.00
Net income (TTM)
-$7.30M
EPS (TTM)
$-8.93
P/E ratio
—
Dividend yield
—
Free cash flow
-$5.20M
Cash
$356K
Total assets
$3.44M
Gross margin
—
52-week range
$2.96 – $9.85
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Other events
Jul 9, 2026
8-K
Entered a material agreement; Change in control; Regulation FD disclosure; Other events
Jun 26, 2026
8-K
Regulation FD disclosure
Jun 25, 2026
8-K
Entered a material agreement; Unregistered sale of equity; Other events
May 28, 2026
10-Q
Quarter ended 2026-03-31
May 15, 2026
8-K
Delisting notice or listing-rule failure
Apr 21, 2026
10-K
Fiscal year ended 2025-12-31
Mar 31, 2026
8-K
Results of operations (earnings release)
Mar 31, 2026
8-K
Exit or disposal costs; Regulation FD disclosure
Mar 25, 2026
8-K
Director or officer change; Amended charter or bylaws; Shareholder vote results
Dec 15, 2025
8-K
Director or officer change
Nov 28, 2025
8-K
Other events
Nov 14, 2025
10-Q
Quarter ended 2025-09-30
Nov 14, 2025
8-K
Entered a material agreement
Oct 30, 2025
8-K
Regulation FD disclosure; Other events
Oct 23, 2025
8-K/A
Entered a material agreement; Terminated a material agreement; Unregistered sale of equity; Item 5.08; Regulation FD disclosure; Other events
Oct 15, 2025
8-K
FORM 8-K
Oct 15, 2025
10-Q
Quarter ended 2025-06-30
Aug 14, 2025
8-K
Other events
Jul 23, 2025
8-K
Results of operations (earnings release)
Jul 9, 2025
8-K
Regulation FD disclosure
Jun 11, 2025
8-K
Delisting notice or listing-rule failure
May 30, 2025
10-Q
Quarter ended 2025-03-31
May 15, 2025
8-K
Results of operations (earnings release)
May 15, 2025
10-K/A
Fiscal year ended 2024-12-31
Apr 7, 2025
10-K
Fiscal year ended 2024-12-31
Mar 31, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Mar 31, 2025
8-K
Regulation FD disclosure; Other events
Nov 22, 2024
10-Q/A
Quarter ended 2024-09-30
Nov 21, 2024
10-Q
Quarter ended 2024-09-30
Nov 19, 2024
8-K
Results of operations (earnings release)
Nov 15, 2024
8-K
Modified rights of security holders; Amended charter or bylaws
Nov 5, 2024
8-K
Shareholder vote results; Other events
Oct 29, 2024
8-K
Regulation FD disclosure; Other events
Aug 28, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
Aug 23, 2024
8-K
Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure
Aug 16, 2024
10-Q
Quarter ended 2024-06-30
Aug 14, 2024
8-K
Director or officer change; Regulation FD disclosure
Aug 13, 2024
8-K
Director or officer change; Amended charter or bylaws; Shareholder vote results; Other events
Aug 9, 2024
8-K
Delisting notice or listing-rule failure
Jul 17, 2024